Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL6053259 | 0.93 | SLC34A1 (0.33) | PGK1PGK2 | |
| SCHEMBL17748719 | 0.93 | KDM4E (0.30) | PGK1PGK2 | |
| SCHEMBL3815164 | 0.79 | CA1 (0.31) | — | |
| Tetrylammonium SCHEMBL3813154 | 0.77 | TSHR (0.36) | — | |
| Potassium Ion SCHEMBL3272040 | 0.73 | SLC34A1 (0.33) | PGK1PGK2 | |
| SCHEMBL15136602 | 0.73 | KDM4E (0.30) | PGK1PGK2 | |
| SCHEMBL15136323 | 0.73 | PGK1 (0.30) | PGK1PGK2 | |
| SCHEMBL16346604 | 0.73 | PGK1 (0.30) | PGK1PGK2 | |
| SCHEMBL12469732 | 0.73 | PGK1 (0.30) | PGK1PGK2 | |
| Silver SCHEMBL18668196 | 0.73 | PGK1 (0.30) | PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1495036-B1 | METHOD FOR THE PRODUCTION OF MONOHYDRO-PERFLUOROALKANES, BIS(PERFLUOROALKYL)PHOSPHINATES, AND PERFLUOROALKYLPHOSPHONATES | MERCK PATENT GMBH (DE) | 2009-08-19 | — | — | EP | disclosed |
| US-7145004-B2 | Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates | MERCK PATENT GESELLSCHAFT (DE) | 2006-12-05 | — | — | US | disclosed |
| US-20050222411-A1 | Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates | MERCK PATENT GMBH (DE) | 2005-10-06 | — | — | US | disclosed |
| EP-1495036-A1 | METHOD FOR THE PRODUCTION OF MONOHYDRO-PERFLUOROALKANES, BIS(PERFLUOROALKYL)PHOSPHINATES, AND PERFLUOROALKYLPHOSPHONATES | MERCK PATENT GmbH (DE) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003087111-A1 | METHOD FOR THE PRODUCTION OF MONOHYDRO-PERFLUOROALKANES, BIS(PERFLUOROALKYL)PHOSPHINATES, AND PERFLUOROALKYLPHOSPHONATES | MERCK PATENT GMBH (DE) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222411-A1 | Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates | PFAS, PFKFB2, PHOSPHO1 | PGK1 670/4885PGK2 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.